KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBT (2016 - 2025)

Historic EBT for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to -$85.1 million.

  • Exact Sciences' EBT rose 9028.7% to -$85.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$203.9 million, marking a year-over-year increase of 8032.27%. This contributed to the annual value of -$203.9 million for FY2025, which is 8032.27% up from last year.
  • Exact Sciences' EBT amounted to -$85.1 million in Q4 2025, which was up 9028.7% from -$17.8 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' EBT registered a high of $1.0 million during Q3 2023, and its lowest value of -$876.0 million during Q4 2024.
  • Moreover, its 5-year median value for EBT was -$104.7 million (2024), whereas its average is -$145.8 million.
  • As far as peak fluctuations go, Exact Sciences' EBT surged by 10068.67% in 2023, and later plummeted by 368849.47% in 2024.
  • Exact Sciences' EBT (Quarter) stood at -$224.9 million in 2021, then surged by 42.22% to -$129.9 million in 2022, then surged by 61.23% to -$50.4 million in 2023, then plummeted by 1638.86% to -$876.0 million in 2024, then soared by 90.29% to -$85.1 million in 2025.
  • Its EBT was -$85.1 million in Q4 2025, compared to -$17.8 million in Q3 2025 and -$57000.0 in Q2 2025.